Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of AP303 in patients with diabetic kidney disease and is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• AP303

Snippet

Sponsor: Alebund Pharmaceuticals | Conditions: Diabetic Kidney Disease | Phase 1 | Status: RECRUITING